Medicare Enrolled
Dr. Mohit Khera, M.D.
Urology Physician · Houston, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khera
Dr. Mohit Khera is an urology physician in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Khera performed 3,198 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Khera received a total of $392,444 from 27 pharmaceutical and/or device companies across 389 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 37% volume in TX
$392,444 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,198
Medicare services
Top 37% in TX for urology physician
Not available
Unique patients (not deduplicated)
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
428 | $25 | $84 |
| Sex hormone binding globulin level test A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream. |
419 | $21 | $118 |
| Total estradiol level test A blood test that measures the total amount of estradiol, a form of estrogen, in the body. |
374 | $27 | $75 |
| PSA test (prostate cancer screening) | 330 | $18 | $91 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
289 | $64 | $250 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
240 | $631 | $2,324 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
191 | $39 | $157 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
190 | $77 | $479 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
107 | $74 | $311 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
106 | $7 | $54 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $93 | $354 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
70 | $3 | $11 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
55 | $160 | $1,217 |
| Tumor marker analysis A laboratory test that analyzes a sample to detect the presence of tumor markers. These markers are substances that may be found in the blood, urine, or body tissues. |
50 | $20 | $43 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
48 | $18 | $91 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
35 | $9 | $130 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
25 | $37 | $155 |
| DHEA-S hormone level test A blood test that measures the level of dehydroepiandrosterone sulfate (DHEA-S), a hormone produced by the adrenal glands. |
23 | $22 | $96 |
| Luteinizing hormone level test A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function. |
23 | $18 | $80 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
21 | $35 | $200 |
| Follicle stimulating hormone (FSH) level A blood test to measure the level of follicle stimulating hormone, a reproductive hormone. |
21 | $18 | $80 |
| Prolactin level test A blood test that measures the amount of prolactin, a hormone produced by the pituitary gland that stimulates milk production, in the body. |
17 | $19 | $78 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $108 | $387 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $111 | $461 |
| Insertion of multicomponent inflatable penile implant | 12 | $663 | $4,062 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$392,444
Total received (2018-2024)
Avg $56,063/year across 7 years
Top 1% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
389
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$56,461
2023
$43,716
2022
$84,609
2021
$57,631
2020
$55,899
2019
$62,585
2018
$31,544
Payments by company (2024)
Boston Scientific Corporation
$34,563
BESINS HEALTHCARE IRELAND LIMITED
$18,676
COLOPLAST CORP
$1,867
Verity Pharmaceuticals Inc.
$1,000
Endo USA, Inc.
$191
PROCEPT BioRobotics Corporation
$64
Astellas Pharma US Inc
$51
Innovation Technologies Inc
$32
Endo Pharmaceuticals Inc.
$18
Top 3 companies account for 97.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$196,150
Endo Pharmaceuticals Inc.
$50,658
BOSTON SCIENTIFIC CORPORATION
$48,973
Antares Pharma, Inc.
$19,351
BESINS HEALTHCARE IRELAND LIMITED
$18,676
Metuchen Pharmaceuticals
$16,454
Acerus Pharmaceuticals Corporation
$12,958
Coloplast Corp
$7,820
Clarus Therapeutics Inc.
$4,490
AbbVie Inc.
$4,400
Marius Pharmaceuticals, LLC
$3,250
TOLMAR Pharmaceuticals, Inc.
$2,370
COLOPLAST CORP
$2,212
Besins Healthcare Ireland Limited
$1,500
ABBVIE INC.
$1,250
Verity Pharmaceuticals Inc.
$1,000
Astellas Pharma US Inc
$240
Endo USA, Inc.
$191
Laborie Medical Technologies Corp.
$125
AMAG Pharmaceuticals, Inc.
$120
Olympus America Inc.
$82
PROCEPT BioRobotics Corporation
$64
Innovation Technologies Inc
$32
Janssen Biotech, Inc.
$29
Ambu Inc.
$19
Vertical Pharmaceuticals, LLC
$16
PFIZER INC.
$15
Top 3 companies account for 75.4% of all-time payments
Associated products mentioned in payments ›
ADVANCE · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · ANDROGEL · AQUABEAM SYSTEM · AVEED · AdVance XP · CLINICAL TRIAL PRODUCT · DIVIGEL · EDEX · ELIGARD · Erleada · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL MALE SUI · GENERAL THERAPIES · GENERAL - ERECTILE DYSFUNCTION · GENERAL - THERAPIES · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · General - Erectile Dysfunction · General - Kidney Stone Disease · General - Therapies · General - Vascular Access · INTRAROSA · IRRISEPT · JATENZO · KYZATREX · NOCDURNA · Natesto · OTREXUP · Porges Coloplast · REZUM · Stendra · TACTRA · TESTOPEL · THERAPIES · TITAN · TLANDO · TOROSA · Titan · Tlando · VISERA ELITE · XIAFLEX · XTANDI · XYOSTED · Xtandi
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
198
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khera is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khera experienced with total testosterone level test?
Based on Medicare claims data, Dr. Khera performed 428 total testosterone level test services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Khera receive payments from pharmaceutical companies?
Yes. Dr. Khera received a total of $392,444 from 27 companies across 389 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khera's costs compare to other urology physicians in Houston?
Dr. Khera's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Houston
Browse urology physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology